N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-5-amine CAS:231278-20-9

N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-5-amine, often referred to by its chemical abbreviation, serves various biomedical purposes due to its pharmacological properties and potential therapeutic benefits. 1. Anticancer Research: This compound is actively studied for its potential in oncology. It demonstrates promising cytotoxic effects against cancer cells, particularly in specific types of tumors. Researchers are investigating its mechanisms of action to develop targeted therapies that can effectively combat cancer with reduced side effects. 2. Drug Development: Researchers are exploring the compound's potential in pharmaceutical development. Studies focus on optimizing its chemical structure to enhance efficacy and bioavailability while minimizing adverse effects. This effort aims to translate scientific findings into new medications that offer improved treatment outcomes for various diseases. 3. Antimicrobial Properties: Preliminary research suggests antimicrobial activity against bacterial pathogens. Investigations are underway to understand its mode of action and assess its effectiveness against drug-resistant strains. This compound shows potential in addressing the global challenge of antimicrobial resistance by offering new therapeutic options. 4. Anti-Inflammatory Potential: The compound exhibits anti-inflammatory properties, indicating its potential in treating inflammatory conditions such as rheumatoid arthritis and inflammatory bowel diseases. Further research is needed to elucidate its mechanisms and assess its clinical efficacy in managing these chronic inflammatory disorders. 5. Other Therapeutic Applications: Beyond its primary uses, ongoing studies explore additional therapeutic applications. These include potential roles in neuroprotection and cardiovascular diseases, leveraging its unique pharmacological profile to explore novel treatment options across various medical conditions. In summary, N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-5-amine shows promise in oncology for cancer treatment, pharmaceutical development, antimicrobial therapy against resistant pathogens, anti-inflammatory treatments, and potential applications in neuroprotection and cardiovascular health. Continued research efforts aim to fully unlock its therapeutic potential and pave the way for innovative medical interventions.